MedTrace Logo

NeoAMR Observational Study in Neonatal Sepsis

NCT03721302 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3202

Last updated 2020-08-19

No results posted yet for this study

Summary

Prospective, multinational, multicentre, observational cohort study of neonatal sepsis in partner institutions. The cohort study will be designed to evaluate health care utilization and current clinical practice and to assess risk factors for and outcomes of babies with neonatal sepsis (culture-negative and culture-positive).

Conditions

  • Neonatal SEPSIS

Interventions

OTHER

Main study clinical sepsis

No intervention-Observational study

OTHER

Microbiology sub study

Analysis of Bacterial isolates

Sponsors & Collaborators

  • St George's, University of London

    collaborator OTHER

  • PENTA Foundation

    collaborator NETWORK

  • Universiteit Antwerpen

    collaborator OTHER

  • Drugs for Neglected Diseases

    lead OTHER

Principal Investigators

  • Mike Sharland · St. George's Hospital, University of London

Eligibility

Max Age
60 Days
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-08-16
Primary Completion
2019-12-31
Completion
2020-02-29

Countries

  • Bangladesh
  • Brazil
  • China
  • Greece
  • India
  • Italy
  • Kenya
  • South Africa
  • Thailand
  • Uganda
  • Vietnam

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03721302 on ClinicalTrials.gov